JB Chemicals and Pharmaceuticals Q4 net profit fell 30.4 percent to 101.4 crore, revenue and EBITDA also declined, but shares rose 2.93 percent to 2215 on the BSE
JB Chemicals and Pharmaceuticals Q4 net profit fell 30.4 percent to 101.4 crore, revenue and EBITDA also declined, but shares rose 2.93 percent to 2215 on the BSE